Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)

CBSE:PRO Revenue

In the year 2025, Societe de Promotion Pharmaceutique du Maghreb had annual revenue of 979.73M MAD with 9.02% growth. Societe de Promotion Pharmaceutique du Maghreb had revenue of 515.52M in the half year ending December 31, 2025, with 22.04% growth.

• Revenue: 979.73M
• Revenue Growth: +9.02%
• P/S Ratio: 1.38
• Revenue / Employee: 2.86M
• Employees: 343
• Market Cap: 1.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	979.73M	81.02M	9.02%
Dec 31, 2024	898.71M	93.20M	11.57%
Dec 31, 2023	805.52M	100.88M	14.32%
Dec 31, 2022	704.64M	74.15M	11.76%
Dec 31, 2021	630.49M	57.30M	10.00%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 5, 2026

Data Sources Report a data error